Business Context and Reporting Period
This Form 8-K reports the consummation of the Initial Public Offering (IPO) and related private placement by Health Sciences Acquisitions Corporation 2 (not Orchestra Biomed Holdings, Inc., as noted in the metadata request). The report date is August 3, 2020, with the IPO consummated on August 6, 2020. The Company is a Cayman Islands exempted company incorporated as a special purpose acquisition company (SPAC) intended to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination.
Key Financial Metrics
- IPO Gross Proceeds: $160,000,000 from the sale of 16,000,000 ordinary shares at $10.00 per share (including full exercise of the underwriter's over-allotment option).
- Private Placement Proceeds: $6,000,000 from the sale of 450,000 private shares and 1,500,000 private warrants to the Sponsor (HSAC 2 Holdings, LLC).
- Total Capital Raised: $166,000,000.
- Trust Account Balance: $160,000,000 deposited as of August 6, 2020, for the benefit of public shareholders.
- Operating Metrics: The filing does not provide revenue, profit, cash flow, or margin data as the Company is a pre-revenue SPAC.
- Debt and Liquidity: No debt is reported. Liquidity is derived from the IPO and private placement proceeds, with $160 million held in trust.
Material Changes
The primary material change is the transition from a private entity to a publicly traded company on The Nasdaq Stock Market LLC under the symbol "HSAQ." This filing marks the entry into definitive agreements including underwriting, trust, escrow, and registration rights agreements necessary to facilitate the public offering and subsequent operations.
Guidance, Outlook, and Risks
- Outlook: The Company intends to complete an initial business combination within a specified timeframe (typically 18-24 months for SPACs, though the specific deadline is in the Registration Statement referenced herein).
- Private Warrants: 1,500,000 private warrants were issued to the Sponsor, exercisable at $11.50 per share. They become exercisable on the later of 30 days after the initial business combination or 12 months from the offering closing and expire five years after the combination.
- Lock-up: The Sponsor agreed not to transfer private shares or warrants until the completion of the initial business combination.
- Risks: Standard SPAC risks apply, including the risk of failing to complete a business combination, which would result in liquidation and return of trust funds to shareholders. The filing notes that an audited balance sheet will be filed within 4 business days of the IPO consummation.
Investor Verification Checklist
- Verify the final audited balance sheet to be filed within 4 business days of August 6, 2020, to confirm the exact cash position and transaction costs.
- Review the Registration Statement (File No. 333-239922 and 333-240318) for the specific deadline to complete the initial business combination.
- Confirm the terms of the Administrative Services Agreement with HSAC 2 Holdings, LLC regarding monthly fees paid to the Sponsor.
- Monitor the status of the $160,000,000 trust account to ensure funds remain segregated for public shareholders.